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Limited understanding of the Rb1 locus hinders genetic and epigenetic analyses of
Retinoblastoma, a childhood cancer of the nervous systems. In this study, we used in
silico tools to investigate and review putative genetic and epigenetic elements of the
Rb1 gene. We report transcription start sites, CpG islands, and regulatory moieties that
are likely to influence transcriptional states of this gene. These might contribute genetic
and epigenetic information modulating tissue-specific transcripts and expression levels of
Rb1. The elements we identified include tandem repeats that reside within or next to CpG
islands near Rb1’s transcriptional start site, and that are likely to be polymorphic among
individuals. Our analyses highlight the complexity of this gene and suggest opportunities
and limitations for future studies of retinoblastoma, genetic counseling, and the accurate
identification of patients at greater risk of developing the malignancy.
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INTRODUCTION
The retinoblastoma gene (Rb1) is one of the most widely
studied tumor suppressors (Vogelstein and Kinzler, 2004).
Retinoblastoma (RB) is a prototype cancer driven in large part
by lesions in Rb1, a well-defined genetic element and clinical tar-
get. Point mutations, deletions, and epigenetic alterations in Rb1
are also associated with a number of other malignancies (De La
Rosa-Velázquez et al., 2007). Recent advances in genomics and
epigenomics have made it possible to study RB in novel ways,
with approaches combining multiple complementary techniques
revealing key genetic and epigenetic steps at the origin of this
malignancy (Reis et al., 2012).
Cryptic genetic and epigenetic variation in Rb1 might con-
tribute variation in the progression and drug response of RB
tumors. It is plausible that differential penetrance and variation in
the age of onset, which have been observed in patients with hered-
itary and non-hereditary RB, are attributed to epigenetic regula-
tion of Rb1 (Kanber et al., 2009). Three CpG islands (CpG106,
42, and 85) potentially involved in regulation of Rb1 expres-
sion have been identified and investigated in detail (Greger et al.,
1989). However, uncovering the genetic and epigenetic complex-
ity of the Rb1 locus remains challenging. This is in part due to
a lack of complete understanding of the cis-regulatory elements
controlling the expression of the gene. Furthermore, evidence of
imprinted expression of Rb1 suggests that epigenetic mechanisms
might play a central role in the regulation of Rb1 (reviewed in
Reis et al., 2012). We expect that comprehensive analyses of the
genetic and epigenetic properties of the human Rb1 gene might
reveal new aspects underlying its regulation. In this study, we have
characterized a number of features of Rb1 and presented some
potential mechanisms that might be involved in regulation of this
gene. Combining the results of several approaches and databanks
will promote a better biological understanding of Rb1, and con-
tribute toward improved clinical management and counseling of
RB patients.
MATERIALS AND METHODS
We combined a set of methods to identify putative functional
elements in the Rb1 locus. Our inferences are based on pub-
licly available databases and re-analyses of experimental data.
Table 1 lists the softwares used in this study. We defined the
Genomic Region under Analysis (GRA) as a sequence that spans
from 2 kb upstream of annotated Transcription start site (TSS)
of Rb1 to the end of the gene. This was based on previous stud-
ies which defined human putative promoter regions as sequences
that correspond to −2000 to +1000 bp relative to the TSS
(Marino-Ramirez et al., 2004).
RESULTS
EXPRESSION OF Rb1 AND mRNA ISOFORMS
According to AceView, Rb1 is expressed at 3.1 times the average
gene. The database provides a comprehensive and non-redundant
sequence representation of public mRNA sequences, and identi-
fied 33 potentially distinct GT-AG introns in Rb1 (Thierry-Mieg
and Thierry-Mieg, 2006). These result in 17 different mRNAs,
10 of which are produced through alternative splicing. There are
3 probable alternative promoters, 3 non-overlapping alternative
last exons, and 3 validated alternative polyadenylation sites
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Table 1 | Databases and softwares used in this study.
Application Program/database Reference/address
Finding mRNA isoforms Ace view www.ncbi.nlm.nih.gov/IEB/Research/Acembly/
UCSC http://genome.ucsc.edu/
Expression analysis Ace view www.ncbi.nlm.nih.gov/IEB/Research/Acembly/
Affymetrix exon array
GNF Gene Expression Atlas2
http://genome.ucsc.edu/
Promoter detection Hidden Markov Model UCSC (http://genome.ucsc.edu/)
CoreBoost_HM Promoter Prediction UCSC (http://genome.ucsc.edu/)
Promoter scan www-bimas.cit.nih.gov/molbio/proscan/
Promoter2 www.cbs.dtu.dk/services/Promoter
Alternative transcription start sites DBTSS http://dbtss.hgc.jp/
Eponine UCSC (http://genome.ucsc.edu/)
SwithGear UCSC (http://genome.ucsc.edu/)
Detection of CpGIs UCSC http://genome.ucsc.edu/
Bona fide CGIs http://epigraph.mpi-inf.mpg.de/download/CpG_islands_revisited/
CpGProD http://pbil.univ-lyon1.fr/software/cpgprod.html
CpGcluster http://bioinfo2.ugr.es/CpGcluster/
CpG-MI tool http://bioinfo.hrbmu.edu.cn/cpgmi/
Weizmann Evolutionary CpG Islands UCSC (http://genome.ucsc.edu/)
Estimation of the CGI’s methylation status Bona fide CGIs http://epigraph.mpi-inf.mpg.de/download/CpG_islands_revisited/
Finding repeated sequences Estimation of repeat variability http://hulsweb1.cgr.harvard.edu/SERV/
Repeat masker http://genome.ucsc.edu/
Inspecting histone marks UCSC http://genome.ucsc.edu/
DNase I hypersensitive sites UCSC http://genome.ucsc.edu/
Transcription factor binding sites CisRed www.cisred.org/
PReMode http://genomequebec.mcgill.ca/PReMod/
ENCODE UCSC (http://genome.ucsc.edu/)
Prediction of insulator sites CTCFBSDB http://insulatordb.uthsc.edu
(http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/). One
variant has a supporting clone (NM_000321.2) in Refseq
database. According to the UCSC browser, there are three differ-
ent transcripts, one of which is represented by Refseq (Figure 1).
Finally, the GNF Atlas indicates that Rb1 is expressed at variable
levels across tissues (supplementary Figure 1).
PROMOTERS AND TSSs
Chromatin state segmentation using Hidden Markov Model
(HMM) (Pedersen et al., 1996) indicates that at least two promot-
ers might be found in the Rb1 region. One promoter is near the
canonical TSS and another is within one of its introns. According
to current annotation, there is a gene named LPAR (P2RY5) within
this intron. Alternative splicing of LPAR results in multiple tran-
script variants. The second active promoter overlaps with TSS of
Rb1 (Figure 1). Promoter prediction with CoreBoost_HM identi-
fies 4 hits in the GRA (Figure 1). CoreBoost_HM integrates DNA
sequence features with epigenetic information to identify RNA
polymeraseIIcore-promoters(Wangetal.,2009). Inaddition,mul-
tiple TSSs were found using Eponine and SwitchGear (Figure 1).
“Eponine” provides a probabilistic method for detecting TSS, with
good specificity and positional accuracy (Down and Hubbard,
2002). “SwithGear” describes the location of TSSs throughout
the genome along with a confidence measure for each TSS based
on experimental evidence (http://genome.ucsc.edu/). Finally, the
DBTSS database, which is based on the TSS sequencing method
(TSS-Seq), suggests that distinct TSSs might be active in different
cell lines (Table 2) (Yamashita et al., 2012). Altogether, the results
point to alternative promoters and TSSs in the Rb1 gene.
DETECTION OF CpGIs
According to the UCSC browser searching criteria for CpGIs (tra-
ditional method), there were 3 CpG islands (Figure 2) in the
Rb1 (CGIs106, 42, and 85). UCSC identifies CpGIs of human
genes using three criteria: (1) GC content greater than 50%, (2)
length greater than 200 bp, and (3) large ratio between observed
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FIGURE 1 | Rb1 gene structure. Transcribed RNAs from this locus identified
by UCSC genome browser. The exons are represented by black blocks.
Different promoters and transcription start sites of Rb1 locus are shown. The
diagram shows a schematic representation of results from different
databases and programs which are described in the text. The yellow circles
show CpG islands identified by UCSC genome browser. There are two red
boxes which show the promoters identified by HMM-Promoter prediction
algorithm. TSSs (Transcription start sites) are recognized by different
algorithms such as CoreBoost, Eponine, and SwitchGear. LPAR is a gene
within Rb1.
Table 2 | Transcription start sites (TSSs) identified in the DBTSS
database for different cell lines.
Cell line TSS position (positions are based on UCSC hg19)
Hela 48878016
DLD1 48877884
Beas2B 48877877
Ramos 48877983
48876242
MCF7 48877937
Table shows the cell lines (left column) and the position of TSSs in the Rb1 gene.
and expected number of CG dinucleotides (Gardiner-Garden and
Frommer, 1987). Further analysis indicates additional putative
segments containing CpGs. The “bona fide” strategy integrates
genomic and epigenomic information to screen functional CGIs
(Bock et al., 2007). We found eight bona fide CpGIs residing
within the Rb1 region (CGI 775-83). Three of them demon-
strated positional overlap or neighborhood with three CpGIs
predicted by traditional methods and previous studies. Only
one of the CpGIs (106 in traditional finding and 775 in Bona
fide CGIs) was near the canonical TSS of Rb1. The remain-
ing CGIs were in intron 2 (Figure 2). Analysis of the targeted
genomic region with the “CpGProD” program points to differ-
ent CGIs over the length of Rb1 (Figure 2 and Table 3). The
program investigates prediction of promoter-overlapping CGIs
with a longer length and greater CpGo/e ratio compared with
non-overlapping start site CGIs (Ponger and Mouchiroud, 2002).
Further, the “CpG cluster” program detects CpGIs based on
the distance between neighboring CpGs. Because a minimum
threshold length is not required, CpG cluster can find short but
fully functional CGIs usually missed by other algorithms. In our
study, most of the CpGs identified by this program overlap with
the bona fide CGI regions (Table 3). Finally, the “Weizmann
Evolutionary CpGIs” identified two different CpGIs (CpG2 and
2.6) (Figure 2). This custom track of UCSC predicts genome’s
regulatory elements with highly conserved sequences. Table 3
shows a comparison of the CpGIs positions identified by different
programs.
ESTIMATION OF THE CGI’s METHYLATION STATUS
Several programs can be used to predict CGIs methylation
status (Carson et al., 2008). The scores reflect the ability of each
CGI to maintain its unmethylated state. All genomic CGIs are
grouped into four sets: B1(0–0.33), B2(0.33–0.50), B3(0.50–
0.67), and B4(0.67–1), whereby CGIs with combined scores>0.5
represent CGIs that are strongly associated with epigenetic
regulatory function (http://epigraph.mpi-inf.mpg.de/download/
CpG_islands_revisited/). Also, we evaluated two other indicators
of methylation status in CGIs: the over-representation of CCGC
motif within sequences of CpG islands (Bock et al., 2007) and
the presence of H3K4me3 marks in CGIs (Su et al., 2010).
We found three CpG islands (CpG775, 779, and 782) within
groups B3 and B4. All these CpG islands had CCGC motif in
their sequences. Also, we observed other regions which were
methylated in different cell lines of ENCODE project (http://
genome.ucsc.edu/cgi-bin/hgTracks?position=chr13:48875883-49
056026&hgsid=347686961&wgEncodeHaibMethyl450=dense).
TANDEM REPEATS
By using “Estimation of Repeat Variability” toolkit, we
found multiple tandem repeats in the GRA (Table 4). Three
characteristics of the repeats (number of repeated units, unit
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FIGURE 2 | The positions of CpG islands in the Rb1 locus. The
first and last blocks in the schematic gene represent the first and
fourth exons of Rb1, respectively. “Bona fide” strategy accounts for
a number of functional CGIs and estimates their strengths (see
scores in the figure). Also, CpGProD program predicts promoter-
overlapping CGIs. “Weizmann CpG islands” predicts highly conserved
CGIs. Although different methods were used, the results are largely
concordant.
length, and purity) were considered to produce a numeric
“VARscore,” which correlates with repeat variability (Legendre
et al., 2007). In our result, CGI-775, which includes the TSS
of Rb1 locus, is over a 3 bp unit VNTR. The sequence of this
VNTR is: GCCGCCGCCACCGCCGCCGCTGCCGCCGCGGA
CCCCCGGCACCGCCGCCGCCGCC. Hence, longer alleles
can add CpGs to the number of methylatable sites. Another
tandem repeat identified by this software is downstream of CpGI
number 6 recognized by CpG cluster. CpGI 6 was not found
by bona fide as a functional island, but we observed that the
CCGC motif is represented 4 times in the segment that includes
CpGI 6 and the VNTR. Also, inspection for transcription factor
binding sites in this segment by “TFSearch” software, indicates
that there is CREB binding site motif in this region. Enrichment
of representation of binding site of this transcription factor
characterizes methylation free CpG islands (Tate and Bird, 1993;
Sunahori et al., 2009).
INSPECTING HISTONE MARKS
We observed H3K4me1 and H3K4me3 through the annotated
core Rb1 promoter (supplementary Figure 2). The observation
was made with data from the ENCODE project. H3K4me1 and
H3K4me3 positive marks were mostly mirroring the acetylated
histones. It is of note that the regions of histone marks mostly
overlapped with CGI-775 and promoters identified by different
programs.
DNase I HYPERSENSITIVE SITES (DNase I HS)
We used DNase Clusters track in UCSC genome browser. In the
Rb1 promoter, positions of the DNase I HS sites vary depending
on cell line assayed. Notably, DNase I HS sites are mostly mapped
to CGI_775, which overlaps with CG106. Also, we found that
some of these hypersensitive sites are overlapped with or adjacent
to other predicted CpGIs.
TRANSCRIPTION FACTOR BINDING SITES
“CisRed” and “PReMode” databases were used to detect the
boundaries of regulatory regions and TFBs motifs distribu-
tion. CisRed summarizes conserved sequence motifs identi-
fied by genome scale motif discovery, similarity, clustering,
co-occurrence, and coexpression calculations (Robertson et al.,
2006). The algorithm used in PReMode predicts transcriptional
regulatory modules (Ferretti et al., 2007) in which a number of
transcription factors can bind and regulate expression of nearby
genes (Ben-Tabou De-Leon and Davidson, 2007; Teif, 2010).
There were three modules concentrated within or next to CpGs
around TSS. Two modules were near the canonical TSS. Finally,
the ENCODE results in UCSC point to regions with abundant
binding of transcription factors.
INSULATOR SITES
A comprehensive collection of experimentally determined and
computationally predicted CTCF binding sites have been curated
in the “CTCFBSDB” database (Bao et al., 2008). We observed 6
putative sites for CTCF binding in GRA, two of which are located
in CpGI-775 (Table 5).
DISCUSSION
Neural progenitor cells dynamically interact with their environ-
ment (Jones and Laird, 1999). The expanded two hit hypothesis
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Table 3 | Comparison of CpGs identified with different programs.
Regions (kb) Traditional CpG finding Bonafide CpGIs (B3 group) CpGProD CpGcluster
1–3.5 CGI106: 1578-2619 CGI775:1429-2956 CG1:1370-3076 #1:1540-1710
#2:1759-2619
#3:2673-2898
10–10.5 No No #4:10015-10235
12–12.5 No No #5:12159-12302
14.5–16 CGI42:15076-15667 No CG2:14857-15723 #6:15038-15446
#7:15560-15667
#8:15839-16103
16–17 CGI85:16754-17975 CGI779:16336-16550 CG3:16486-20182 #9:16592-16986
17–18 No #10:17039-17211
#11:17254-17430
#12:17494-17738
#13:17786-17975
18–19 No No #14:18458-18645
#15:18807-19080
19–20.5 No CGI782: 19195-19545 #16:19167-19443
#17:19596-19672
#18:19823-20089
155–165 No No CG4:163702-164409 #19:155929-156023
#20:156294-156415
#21:163774-164177
Although each algorithm has its own strategy, there are some concordances between the results. For simplicity, we have divided the Genomic Region under Analysis
(GRA) into smaller segments (First column).
Table 4 | Tandem repeats in Rb1.
Consensus sequence Start-end
GCC* 2194–2246
CA** 14974–15038
TG 44625–44668
TG 104353–104389
AGTCATCTTCTACCAAACC
TCACCTCCAGCATTGGGGA
GCACACTTCAACACG
125368–126744
AAAC 128996–129033
TTCT 158141–158239
Repeats were recognized by the “Estimation of Repeat variability” toolkit and
have Var score above 0.5. Positions are relative to the nucleotide in −2 kb of the
canonical Rb1 transcription start site.
*Overlapped with CpG # 775.
**Neighborhood with CpG #6 identified by CpG cluster.
proposes that both genetic and epigenetic aberrations are
involved in silencing of tumor suppressor genes in cancers such
as RB (Jones and Laird, 1999). Studies have shown the role of epi-
genetic mechanisms in Rb1 regulation (Reviewed in Reis et al.,
2012), but the exact elements and their relation with cis regulatory
elements already identified as important for Rb1 expression has
Table 5 | CTCF binding motifs within the Genomic Region under
Analysis.
Motif sequence Motif start location
CCGGCCTGGAGGGGGTGGTT 1796
GGAACTGCA 2597
The positions are relative to −2 kb of the canonical transcription start site of the
Rb1 gene.
remained elusive. Here we used in silico analyses and databases to
identify and summarize putative regulatory elements that might
contribute to Rb1 regulation. Identification of these elements
suggests new venues for understanding Rb1 expression and its
contribution to disease states. The analyses reinforce the notion
that a variety of distinct epigenetic and genetic elements are
involved in the control of the activity of the human Rb1 gene.
A study by Greger et al. (1989) was among the first to pro-
vide evidence that changes in the methylation of Rb1might play a
role in the emergence and progression of RB tumors. They found
that CpG106, which overlaps the Rb1 promoter and exon E1, is
methylated in some RB cases. Two other CpGs (CpG 42 and 85)
were investigated in other studies. Kanber et al. (2009) observed
that an alternative transcript of Rb1 is preferentially expressed
from the maternal allele. It seems that imprinted expression
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of Rb1 is linked to a differentially methylated CpG island in
intron 2 of this gene (CpG-85) (Kanber et al., 2009). Also, it has
been reported that CpG 42 is biallelically methylated, whereas
CpG-106 is biallelically unmethylated (Buiting et al., 2010).
We identified additional CpG islands in the Rb1 locus and
sought to assess their epigenetic state by evaluating other data
such as co-occurrence of histone modifications, DNAse 1 sensi-
tivity, transcription factor binding sites, and presence of genomic
insulators. One possibility is that these genetic and epigenetic
features cooperate to fine tune Rb1 regulation. Our observa-
tions highlight two points. First, the Rb1 locus includes multiple
genomic elements exhibiting potential sensitivity to differential
DNA methylation and histone modification. Independent tools
identifiedmultiple CpG islands in the locus. In spite of differences
between softwares, all of them pointed to multiple CpGs, some
of which were corroborated by multiple lines of evidence. These
are promising targets for downstream functional analysis. Second,
repeats occur within or next to some CpG islands. Hence we
expect that the methylation status of the Rb1 regulatory regions in
genomes of different individuals might be affected by repeat num-
ber variations in nearby sequences. The potential contribution of
these regions to the epigenetic regulation of Rb1 alleles might be
worthy of further study. Individual methylation profile might lead
to variable expressivity and penetrance in different patients.
Several mammalian genes contain more than a single TSS
(Valen et al., 2009) and Rb1 does not appear to be an excep-
tion. Genes with alternative promoters, often display only one
promoter with a CGI (Cheong et al., 2006). On the other hand,
most of the putative alternative promoters of Rb1 are distributed
in or next to putative CpG islands. Since methylation sensitive
regions carry distinctly different information about gene expres-
sion and exhibit different sensitivity to regulatory signals, this
type of positioning should not be neglected. Besides, DNAmethy-
lation appears to play a significant role in differential usage of
alternative promoters and be related to functional diversification
between CpGI-containing promoters and CpGI-less promoters.
Furthermore, chromatin marks and transcription elements such
as enhancers or insulators could cause differential expression lev-
els in Rb1 or even differential usage of the gene’s TSSs. The
presence of multiple regulatory elements within the locus confers
combinatorial control of regulation through which the number of
unique expression states can increase (Maston et al., 2006).
The distribution and amount of histone marks like H3K4me1-
3 provide a basis for nucleosome positioning in the Rb1 locus.
H3K4me1 is associated with enhancers and DNA regions down-
stream of TSSs. The H3K4me3 histone mark is associated with
promoters that are active or poised to be activated (Karliæ et al.,
2010). This histone mark seems to be an indicator of functional
CpG islands (Su et al., 2010). We observed an overlap between the
regions including this mark and predicted CpGIs (supplementary
Figure 2).
It has been reported that DNA methylation correlates with
DNase 1 hypersensitivity (Crawford et al., 2006). We found
that DNase 1 hypersensitive regions mapped to CGI_775. This
CpG island overlaps with the canonical promoter of Rb1 and
this observation is in agreement with studies indicating that
regulatory regions in the promoters tend to be DNase sensitive
(Crawford et al., 2006). Noteworthy, we observed several CTCF
binding sites in the Rb1 locus. In vertebrates, the transcription
regulator CCCTC-binding factor (CTCF) is the only trans-acting
factor that is a primary part of insulator sequences that block
the interaction between enhancers and promoters (Ohlsson et al.,
2001). Hence, CTCF is at the core of the machinery that exerts
epigenetic control of diverse imprinted loci and participates in
promoter activation and repression. Evidence points toward a
role for the 11-zinc finger CCCTC-binding factor (CTCF) in the
establishment of DNA methylation free zones and the regula-
tion of cell cycle–related genes (Tang et al., 2002; Filippova et al.,
2005). CTCF-bound insulators separate transcriptionally active
and silent chromatin domains, with their function depending
strongly on the local status of DNA methylation and chromatin
modifications. It has been suggested that active genes have a DNA
fragment with insulator properties and CTCF binding sites in
their 5′ ends (Filippova et al., 2005).
Numerous experimental and clinical studies investigate the
role of DNA methylation and other epigenetic marks in human
diseases (Kanwal and Gupta, 2012). However, in spite of genome-
wide patterns, the association between genomic polymorphisms
and altered epigenetic status of specific genes is elusive. One
interesting possibility is that genetic variations in the Rb1 gene
(including VNTRs) might contribute to the methylation sta-
tus of the region. Hence, experimental methylation analysis
would benefit most if coupled with the sequencing of primary
genomic samples. Furthermore, genetic variations in repeti-
tive segments not usually targeted in mutation screens might
enable a better understanding of unexpected confounders due
to personal genome variation. The proposed set of Rb1 regu-
latory elements offers venues to understand the developmen-
tal dynamics and individual variation in the expression of
the Rb1 gene. Altogether, we expect that interactions between
genetic and epigenetic elements of Rb1 might cause tissue-
specific alternative transcripts, different expression level, and
possibly variable penetrance and disease severity in patients
with RB.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fgene.
2014.00002/abstract
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